Article Information
History
- September 11, 2015.
Article Versions
- Version 1 (September 6, 2015 - 10:35).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zhaleh Safikhani1,2,
- Mark Freeman1,
- Petr Smirnov1,
- Nehme El-Hachem3,
- Adrian She1,
- Rene Quevedo1,2,
- Anna Goldenberg4,5,
- Nicolai Juul Birkbak6,
- Christos Hatzis7,8,
- Leming Shi9,10,
- Andrew H Beck11,
- Hugo JWL Aerts12,13,
- John Quackenbush14,15 and
- Benjamin Haibe-Kains1,2,5
- 1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
- 2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
- 3Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada
- 4Hospital for Sick Children, Toronto, Ontario, Canada
- 5Department of Computer Science, University of Toronto, Toronto, Ontario, Canada
- 6University College London, London, United Kingdom
- 7Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut; USA
- 8Yale Cancer Center, Yale University, New Haven, Connecticut, USA
- 9Fudan University, Shanghai City, China
- 10University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
- 11Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. USA
- 12Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. USA
- 13Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
- 14Department of Biostatistics and Computational Biology and Center for Cancer Computational Biology, Boston, Massachusetts, USA
- 15Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA